Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use: an overview
For the 28 member states of the European Union, Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use, which repeals Directive 2001/20/EC, represents a substantial innovation in the procedures for authorising clinical trials and for handling all the subsequent stages. It...
Main Author: | Carlo Petrini |
---|---|
Format: | Article |
Language: | English |
Published: |
Istituto Superiore di Sanità
2014-12-01
|
Series: | Annali dell'Istituto Superiore di Sanità |
Subjects: | |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0021-25712014000400004&lng=en&tlng=en |
Similar Items
-
Some comments on the new regulations governing Ethics Committees in Italy
by: Carlo Petrini
Published: (2014-06-01) -
Main changes in European Clinical Trials Regulation (No 536/2014)
by: E. Tenti, et al.
Published: (2018-09-01) -
Los ensayos clínicos en colectivos vulnerables en el Reglamento 536/2014 Clinical trials on vulnerable groups in Regulation 536/2014
by: Miguel Vieito Villar
Published: (2015-02-01) -
Value of substitute consent and autonomy of research participants in Regulation (EU) No 536/2014
by: Rafał Patryn, et al.
Published: (2020-12-01) -
On the paradoxes of informed consent: strictness with unlikely risks, tolerance with certain harm
by: Carlo Petrini
Published: (2013-03-01)